Status:

TERMINATED

Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum

Lead Sponsor:

Nordsjaellands Hospital

Collaborating Sponsors:

Bispebjerg Hospital

Aarhus University Hospital

Conditions:

Hyperemesis Gravidarum

Nausea Gravidarum

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

Brief Summary

The aim is to investigate the efficacy of mirtazapine and ondansetron as treatment for hyperemesis gravidarum(HG). The setup is a double-blind multicenter trial where patients suffering from HG will ...

Eligibility Criteria

Inclusion

  • Written informed consent obtained before any trial related procedures are performed
  • Female age \>18 years
  • Pregnant woman with gestational age between 5+0 and 19+6
  • Nausea and vomiting without other obvious reason
  • PUQE-24 score ≥13 OR PUQE-24 score ≥7 AND
  • weight loss \>5% of pre-pregnancy weight and/or
  • hospitalisation due to nausea and vomiting of pregnancy
  • Singleton pregnancy
  • The subject must be willing and able to comply with trial protocol

Exclusion

  • Mola pregnancy, multiple gestation or non-vital pregnancy
  • Nausea and vomiting of other aetiology than NVP
  • Allergic to selective 5-HT3-receptor antagonists
  • Ongoing treatment with antidepressant medication
  • Pre-existing diagnosis of chronic kidney disease, diabetes type 1 or 2, significant cardiac disease (incl. long QT syndrome), epilepsy, HIV. In case of other pre-existing conditions subjects might be excluded based on individual assessment by an MD
  • Elevated liver enzymes (ALAT\>150 U/l)
  • Elevated creatinine (\>100 µmol/l)
  • ECG showing long QT-syndrome (QTc \>460msek)
  • Weekly alcohol intake \>2 units of alcohol
  • Not able to take medicine orally
  • Not able to understand spoken and/or written Danish
  • Participation in another investigational drug trial within current pregnancy

Key Trial Info

Start Date :

March 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2022

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT03785691

Start Date

March 1 2019

End Date

July 31 2022

Last Update

January 30 2023

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Department of Gynaecology and Obstetrics, Aarhus University Hospital

Aarhus, Denmark, 8200

2

Department of Gynaecology and Obstetrics, Rigshospitalet

Copenhagen, Denmark, 2100

3

Department of Gynaecology and Obstetrics, Herlev Hospital

Herlev, Denmark, 2730

4

Department of Gynaecology and Obstetrics, Nordsjællands Hospital

Hillerød, Denmark, 3400